Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Irinotecan × Breast × Clear all

Phase

Status

Sponsor Class

OTHER 18 INDUSTRY 9 NIH 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17 Thoracic 5 Sarcoma 1 NET 1 Endocrine 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Tamoxifen 9 Capecitabine 9 Trastuzumab 8 Docetaxel 8 Exercise 7 pyrotinib 6 Letrozole 6 Gemcitabine 6 Cyclophosphamide 6 Control Groups 6 Vinorelbine 5 Paclitaxel 5 Indocyanine Green 5 Carboplatin 5 exemestane 4 Doxorubicin 4 Anastrozole 4 dalpiciclib 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Injections 3 Fulvestrant 3 Epirubicin 3 Drug Therapy 3 Cisplatin 3 pertuzumab 2 ferumoxides 2 eribulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01501669 2012-07-18

PROCEED

National Cancer Center, Korea

Phase 3 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡